ST葫芦娃 (605199)

Hainan Huluwa Pharmaceutical Group Co., Ltd.

ASH

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 40010.88
  • Circulating A-Shares(W): 40010.88
  • Earnings Per Share(RMB): -0.0300
  • Net Assets Per Share(RMB): 1.7228
  • Operating Revenue(W RMB): 68271.99
  • Total Profit(W RMB): -321.97
  • **Net Profit Attributable to Parent(W RMB) **: -1121.39
  • Net Profit Growth Rate(%): 90.46
  • Weighted Return on Equity(%): -1.6100
  • Operating Cash Flow Per Share(RMB): 0.1460
  • Undistributed Profit Per Share(RMB): -0.1655
  • Capital Reserve Per Share(RMB): 0.7262

2. Main Business

The main business covers:

  • Research, development, production, and sales of proprietary Chinese medicines and chemical drugs.

3. Company Basic Information

  • Company Name: Hainan Huluwa Pharmaceutical Group Co., Ltd.
  • Listing Date: 2020-07-10
  • Industry: Pharmaceuticals & Healthcare - Traditional Chinese Medicine
  • Address: No. 8 Yaogu Fourth Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Haikou City, Hainan Province, China
  • Website: https://www.huluwayaoye.com/
  • Company Profile: The company was established through the overall change of Huluwa Limited. Approved by the shareholders' meeting of Huluwa Limited and the company's founding meeting, it was converted into a joint stock company based on the audited net assets as of December 31, 2015, and completed industrial and commercial registration on March 8, 2016.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hainan Huluwa Investment Development Co., Ltd. General Legal Person 16707.90 41.76
2 Zhejiang Fuwang Jude Health Development Co., Ltd. General Legal Person 5751.90 14.38
3 Hangzhou Zhongjiarui Management Partnership (Limited Partnership) General Legal Person 2752.70 6.88
4
5
6
7
8
9
10

5. Concept Sectors

  • ST Sector
  • Hainan Free Trade Port
  • Childcare Concept
  • Generic Drugs
  • Helicobacter Pylori
  • Hepatitis Concept
  • Innovative Drugs
  • Yesterday Limit Up
  • Specialized, Refined, Unique, and New (SRUN)

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information